The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor α transcriptional activity

Molecular and Cellular Biology

Volumn 27, Issue 17, 2007, Pages 5933-5948

  Peterson, Theresa J ^a,b   Karmakar, Sudipan ^a   Pace, Margaret C ^a   Gao, Tong ^a   Smith, Carolyn L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANTIESTROGEN; CYCLIN D1; ESTROGEN RECEPTOR ALPHA; HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 3; HORMONE RECEPTOR STIMULATING AGENT; NUCLEAR RECEPTOR COREPRESSOR; PROGESTERONE RECEPTOR; PROTEIN BNIP3; PROTEIN PS2; RETINOIC ACID; STEROID RECEPTOR COACTIVATOR 3; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SMRT; UNCLASSIFIED DRUG; VITAMIN D;

ARTICLE; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL TYPE; CHROMATIN IMMUNOPRECIPITATION; COMPLEX FORMATION; ESTROGEN RESPONSIVE ELEMENT; GENE ACTIVATION; GENE SILENCING; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA-BINDING PROTEINS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR MODULATORS; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MICE; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; RNA, SMALL INTERFERING; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TRANSCRIPTION, GENETIC;

EID: 34548307042     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00237-07     Document Type: Article

References (84)

1. Agoulnik, I. U., W. C. Krause, W. E. I. Bingman, H. T. Rahman, M. Amrikachi, G. E. Ayala, and N. L. Weigel. 2003. Repressors of androgen and progesterone receptor action. J. Biol. Chem. 278:31136-31148.
2. Augereau, P., F. Miralles, V. Cavailles, C. Gaudelet, M. Parker, and H. Rochefort. 1994. Characterization of the proximal estrogen-responsive element of human cathepsin D gene. Mol. Endocrinol. 8:693-703.
3. Baek, S. H., K. A. Ohgi, D. W. Rose, E. H. Koo, C. K. Glass, and M. G. Rosenfeld. 2002. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-κB and β-amyloid precursor protein. Cell 110:55-67.
4. Baniahmad, A., I. Ha, D. Reinberg, S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley. 1993. Interaction of human thyroid hormone receptor beta with transcription factors TFIIB may mediate target gene derepression and activation by thyroid hormone. Proc. Natl. Acad. Sci. USA 90:8832-8836.
5. Berghagen, H., E. Ragnhildstveit, K. Krogsrud, G. Thuestad, J. Apriletti, and F. Saatcioglu. 2002. Corepressor SMRT functions as a coactivator for thyroid hormone receptor T3Rα from a negative hormone response element. J. Biol. Chem. 277:49517-49522.
6. Berrevoets, C. A., A. Umar, J. Trapman, and A. O. Brinkmann. 2004. Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR). Biochcm. J. 379:731-738.
7. Bourdeau, V., J. Deschênes, R. Métivier, Y. Nagai, D. Nguyen, N. Bretschneider, F. Gannon, J. H. White, and S. Mader. 2004. Genome-wide identification of high-affinity estrogen response elements in human and mouse. Mol. Endocrinol. 18:1411-1427.
8. Carroll, J. S., X. S. Liu, A. S. Brodsky, W. Li, C. A. Meyer, A. J. Szary, J. Eeckhoute, W. Shao, E. V. Hestermann, T. R. Geistlinger, E. A. Fox, P. A. Silver, and M. Brown. 2005. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122:33-43.
9. Carroll, J. S., C. A. Meyer, J. Song, W. Li, T. R. Geistlinger, J. Eeckhoute, A. S. Brodsky, E. K. Keeton, K. C. Fertuck, G. F. Hall, Q. Wang, S. Bekiranov, V. Sementchenko, E. A. Fox, P. A. Silver, T. R. Gingeras, X. S. Liu, and M. Brown. 2006. Genome-wide analysis of estrogen receptor binding sites. Nat. Genet. 38:1289-1297.
10. Castro-Rivera, E., I. Samudio, and S. Safe. 2001. Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements. J. Biol. Chem. 276:30853-30861.
11. Cavarretta, I. T. R., R. Mukopadhyay, D. M. Lonard, L. M. Cowsert, C. F. Bennett, B. W. O'Malley, and C. L. Smith. 2002. Reduction of coactivator expression by antisense oligodeoxynucleotides inhibits ERα transcriptional activity and MCF-7 proliferation. Mol. Endocrinol. 16:253-270.
12. Chen, C. D., D. S. Welsbie, C. Tran, S. H. Baek, R. Chen, R. Vessella, M. G. Rosenfeld, and C. L. Sawyers. 2004. Molecular determinants of resistance to antiandrogen therapy. Nat. Med. 10:33-39.
13. Chen, D., K. Umesono, and R. M. Evans. 1996. SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. Proc. Natl. Acad. Sci. USA 93:7567-7571.
14. Chen, J. D., and R. M. Evans. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457.
15. Cheng, S., S. Brzostek, S. R. Lee, A. N. Hollenberg, and S. P. Balk. 2002. Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor. Mol. Endocrinol. 16:1492-1501.
16. Coleman, K. M., M. Dutertre, A. El-Gharbawy, B. G. Rowan, N. L. Weigel, and C. L. Smith. 2003. Mechanistic differences in the activation of estrogen receptor-α (ERα)- and ER-β-dependcnt gene expression by cAMP signaling pathway(s). J. Biol. Chem. 278:12834-12845.
17. Cote, S., S. McNamara, D. Brambilla, A. Bianchini, G. Rizzo, S. Victoria del Rincon, F. Grignani, C. Nervi, and W. H. Miller. 2004. Expression of SMRTβ promotes ligand-induced activation of mutated and wild-type retinoid receptors. Blood 104:4226-4335.
18. Dobrzycka, K. M., S. M. Townson, S. Jiang, and S. Oesterreich. 2003. Estrogen receptor corepressors - a role in human breast cancer? Endocr. Relat. Cancer 10:517-536.
19. Dotzlaw, H., M. Papaioannou, U. Moehren, F. Claessens, and A. Baniahmad. 2003. Agonist-antagonist coactivator and corepressor interplay on the human androgen receptor. Mol. Cell. Endocrinol. 213:79-85.
20. Dubik, D., and R. P. Shiu. 1992. Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7:1587-1594.
21. Dutertre, M., and C. L. Smith. 2003. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-α: regulation by phosphorylation sites in the A/B region depends on other receptor domains. Mol. Endocrinol. 17:1296-1314.
22. Fujita, T., Y. Kobayashi, O. Wada, Y. Tateishi, L. Kitada, Y. Yamamoto, H. Takashima, A. Murayama, T. Yano, T. Baba, S. Kato, Y. Kawabe, and J. Yanagisawa. 2003. Full activation of estrogen receptor alpha activation function-1 induces proliferation of breast cancer cells. J. Biol. Chem. 278:26704-26714.
23. Glass, C. K., and M. G. Rosenfeld. 2000. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14:121-141.
24. Goodson, M. L., B. A. Jonas, and M. L. Privalsky. 2005. Alternative mRNA splicing of SMRT creates functional diversity by generating corepressor isoforms with different affinities for different nuclear receptors. J. Biol. Chem. 280:7493-7503.
25. Guenther, M. G., O. Barak, and M. A. Lazar. 2001. The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol. Cell. Biol. 21:6091-6101.
26. Guenther, M. G., W. S. Lane, W. Fischle, E. Verdin, M. A. Lazar, and R. Shiekhattar. 2000. A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes Dev. 14:1048-1057.
27. Heinzel, T., R. M. Lavinsky, T.-M. Mullen, M. Soderstrom, C. D. Laherty, J. Torchia, W.-M. Yang, G. Brard, S. D. Ngo, J. R. Davie, E. Seto, R. N. Eisenman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1997. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387:43-48.
28. Hodgson, M. C., I. Astapova, S. Cheng, L. J. Lee, M. C. Verhoeven, E. Choi, S. P. Balk, and A. N. Hollenberg. 2005. The androgen receptor recruits nuclear receptor corepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists. J. Biol. Chem. 280:6511-6519.
29. Horlein, A. J., A. M. Naar, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kanei, M. Soderstrom, and C. K. Glass. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404.
30. Huang, H.-J., J. D. Norris, and D. P. McDonnell. 2002. Identification of a negative regulatory surface within estrogen receptor a provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists. Mol. Endocrinol. 16:1778-1792.
31. Ishizuka, T., and M. A. Lazar. 2003. The N-CoR/histone deacetylase 3 complex is required for repression by thyroid hormone receptor. Mol. Cell. Biol. 23:5122-5131.
32. Jaber, B. M., T. Gao, L. Huang, S. Karmakar, and C. L. Smith. 2006. The pure estrogen receptor antagonist ICI 182,780 promotes a novel interaction of estrogen rcceptor-α with the 3′,5′-cyclic adenosine monophosphate response element-binding protein-binding protein/p300 coactivators. Mol. Endocrinol. 20:2695-2710.
33. Jackson, T. A., J. K. Richer, D. L. Bain, G. S. Takimoto, L. Tung, and K. B. Horwitz. 1997. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. Mol. Endocrinol. 11:693-705.
34. Jepsen, K., O. Hermanson, T. M. Onami, A. S. Gleiberman, V. Lunyak, R. J. McEvilly, R. Kurokawa, V. Kumar, F. Liu, E. Seto, S. M. Hedrick, G. Mandel, C. K. Glass, D. W. Rose, and M. G. Rosenfeld. 2000. Combinatorial roles of the nuclear receptor corepressor in transcription and development. Cell 102:753-763.
35. Jiang, S., R. Meyer, K. Kang, C. K. Osborne, J. Wong, and S. Oesterreich. 2006. Scaffold attachment factor SAFB1 suppresses estrogen receptor a-mediated transcription in part via interaction with nuclear receptor corepressor. Mol. Endocrinol. 20:311-320.
36. Jung, D.-J., S.-K. Lee, and J. W. Lee. 2001. Agonist-dependent repression mediated by mutant estrogen receptor a that lacks the activation function 2 core domain. J. Biol. Chem. 276:37280-37283.
37. Jung, S. Y., H. Luo, A. Malovannaya, J. Zhang, J. Qin, and M. A. Lazar. 2005. Characterization of nuclear receptor corepressor complexes. NURSA datasets. [Online.] http://www.nursa.org/10.1621/datasets.01002.
38. Kao, H. Y., M. Downes, P. Ordentlich, and R. M. Evans. 2000. Isolation of a novel histone deacetylase reveals that class I and class II deacetylascs promote SMRT-mediated repression. Genes Dev. 14:55-66.
39. Keeton, E. K., and M. Brown. 2005. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-α and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT. Mol. Endocrinol. 19:1543-1554.
40. 3 receptor signalling in prostate cancer cells. Oncogene 23:6712-6725.
41. Kushner, P. J., D. A. Agard, G. L. Greene, T. S. Scanlan, A. K. Shiau, R. M. Uht, and P. Webb. 2000. Estrogen receptor pathways to AP-1. J Steroid Biochem. Mol. Biol. 74:311-317.
42. Laganière, J., G. Deblois, C. Lefebvre, A. R. Bataille, F. Robert, and V. Giguère. 2005. Location analysis of estrogen receptor a target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc. Natl. Acad. Sci. USA 102:11651-11656.
43. Lavinsky, R. M., K. Jepsen, T. Heinzel, J. Torchia, T.-M. Mullen, R. Schiff, A. L. Del-Rio, M. Ricote, S. Ngo, J. Gemsch, S. G. Hilsenbeck, C. K. Osborne, C. K. Glass, M. G. Rosenfeld, and D. W. Rose. 1998. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc. Natl. Acad. Sci. USA 95:2920-2925.
44. Levin, E. R. 2005. Integration of the extranuclear and nuclear actions of estrogen. Mol. Endocrinol. 19:1951-1959.
45. Li, J., J. Wang, J. Wang, Z. Nawaz, J. M. Liu, J. Qin, and J. Wong. 2000. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J. 19:4342-4350.
46. Li, X., E. A. Kimbrel, D. J. Kenan, and D. P. McDonnell. 2002. Direct interactions between corepressors and coactivators permit the integration of nuclear receptor-mediated repression and activation. Mol. Endocrinol. 16: 1482-1491.
47. Liao, G., L.-Y. Chen, A. Zhang, A. Godavarthy, F. Xia, J. C. Ghosh, H. Li, and J. D. Chen. 2003. Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT. J. Biol. Chem. 278:5052-5061.
48. Liu, X. F., and M. K. Bagchi. 2004. Recruitment of distinct chromatin-modifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo. J. Biol. Chem. 279:15050-15058.
49. Lonard, D. M., and B. W. O'Malley. 2006. The expanding cosmos of nuclear receptor coactivators. Cell 125:411-414.
50. Loven, M. A., V. S. Likhite, I. Choi, and A. M. Nardulli. 2001. Estrogen response elements alter coactivator recruitment through allosteric modulation of estrogen receptor β conformation. J. Biol. Chem. 276:45282-45288.
51. Malartre, M., S. Short, and C. Sharpe. 2006. Xenopus embryos lacking specific isoforms of the corepressor SMRT develop abnormal heads. Dev. Biol. 292:333-343.
52. McDonnell, D. P., D. L. Clemm, T. Hermann, M. E. Goldman, and J. W. Pike. 1995. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol. Endocrinol. 9:659-669.
53. McDonnell, D. P., R. A. Scott, S. A. Kerner, B. W. O'Malley, and J. W. Pike. 1989. Functional domains of the human vitamin D3 receptor regulate osteocalcin gene expression. Mol. Endocrinol. 3:635-644.
54. Métivier, R., G. Penot, R. P. Carmouche, M. R. Hübner, G. Reid, S. Denger, D. Manu, H. Brand, M. Kos, V. Benes, and F. Gannon. 2004. Transcriptional complexes engaged by apo-estrogen receptor-α isoforms have divergent outcomes. EMBO J. 23:3653-3666.
55. Métivier, R., A. Stark, G. Flouriot, M. R. Hübner, H. Brand, G. Penot, D. Manu, S. Denger, G. Reid, M. Kos, R. B. Russell, O. Kah, F. Pakdel, and F. Gannon. 2002. A dynamic structural model for estrogen receptor-α activation by ligands, emphasizing the role of interactions between distant A and E domains. Mol. Cell 10:1019-1032.
56. Morrison, A. J., R. E. Herrick, E. C. Heinsohn, R. Schiff, and C. K. Osborne. 2003. Dominant-negative nuclear receptor corepressor relieves transcriptional inhibition of retinoic acid receptor but does not alter the agonist/ antagonist activities of the tamoxifen-bound estrogen receptor. Mol. Endocrinol. 17:1543-1554.
57. Nagy, L., H.-Y. Kao, J. D. Love, C. Li, E. Banayo, J. T. Gooch, V. Krishna, K. Chatterjee, R. M. Evans, and J. W. R. Schwabe. 1999. Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev. 13:3209-3216.
58. Nagy, L., H. Y. Kao, D. Chakravarti, R. J. Lin, C. A. Hassig, D. E. Ayer, S. L. Schreiber, and R. M. Evans. 1997. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89:373-380.
59. Nawaz, Z., D. M. Lonard, C. L. Smith, E. Lev-Lehman, S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley. 1999. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol. Cell. Biol. 19:1182-1189.
60. Nettles, K. W., and G. L. Greene. 2005. Ligand control of coregulator recruitment to nuclear receptors. Annu. Rev. Physiol. 67:309-333.
61. Nilsson, S., S. Mäkelä, E. Treuter, M. Tujague, J. Thomsen, G. Andersson, E. Enmark, K. Pettersson, M. Warner, and J.-Å. Gustafsson. 2001. Mechanisms of estrogen action. Physiol. Rev. 81:1535-1565.
62. Ordentlich, P., M. Downes, W. Xie, A. Genin, N. B. Spinner, and R. M. Evans. 1999. Unique forms of human and mouse nuclear receptor corepressor SMRT. Proc. Natl. Acad. Sci. USA 96:2639-2644.
63. Perissi, V., A. Aggarwal, C. K. Glass, D. W. Rose, and M. G. Rosenfeld. 2004. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116:511-526.
64. Prall, O. W., E. M. Rogan, E. A. Musgrove, C. K. Watts, and R. L. Sutherland. 1998. c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry. Mol. Cell. Biol. 18:4499-4508.
65. Privalsky, M. L. 2004. The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu. Rev. Physiol. 66:315-360.
66. Rio, M. C., and P. Chambon. 1990. The pS2 gene, mRNA, and protein: a potential marker for human breast cancer. Cancer Cells 2:269-274.
67. Rosenfeld, M. G., V. V. Lunyak, and C. K. Glass. 2006. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 20:1405-1428.
68. Safe, S. 2001. Transcriptional activation of genes by 17β-estradiol through estrogen receptor-Sp1 interactions. Vit. Horm. 62:231-252.
69. Shang, Y., and M. Brown. 2002. Molecular determinants for the tissue specificity of SERMs. Science 295:2465-2468.
70. Shang, Y., X. Hu, J. DiRenzo, M. A. Lazar, and M. Brown. 2000. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852.
71. Smith, C. L., Z. Nawaz, and B. W. O'Malley. 1997. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol. Endocrinol. 11:657-666.
72. Smith, C. L., and B. W. O'Malley. 2004. Coregulator funtion: a key to understanding tissue specificity of selective receptor modulators. Endocr. Rev. 25:45-71.
73. Soller, M. J. 2006. Confirmation of the high frequency of the TMPRSS2/ ERG fusion gene in prostate cancer. Genes Chromosomes Cancer 45:717-719.
74. Tzukerman, M. T., A. Esty, D. Santiso-Mere, P. Danielian, M. G. Parker, R. B. Stein, J. W. Pike, and D. P. McDonnell. 1994. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8:21-30.
75. Walters, M. R., M. Dutertre, and C. L. Smith. 2002. SKF-82958 is a subtype-selective estrogen receptor-α (ERa) agonist that induces functional interactions between ERα and AP-1. J. Biol. Chem. 277:1669-1679.
76. Webb, P., P. Nguyen, and P. J. Kushner. 2003. Differential SERM effects on corepressor binding dictate ERα activity in vivo. J. Biol. Chem. 278:6912-6920.
77. Yoon, H.-G., D. W. Chan, Z. Q. Huang, J. Li, J. D. Fondell, J. Qin, and J. Wong. 2003. Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J. 22:1336-1346.
78. Yoon, H.-G., Y. Choi, P. A. Cole, and J. Wong. 2005. Reading and function of a histone code involved in targeting corepressor complexes for repression. Mol. Cell. Biol. 25:324-335.
79. Yoon, H.-G., and J. Wong. 2006. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor. Mol. Endocrinol. 20:1048-1060.
80. Yu, J., C. Palmer, T. Alenghat, Y. Li, G. Kao, and M. A. Lazar. 2006. The corepressor silencing mediator for retinoid and thyroid hormone receptor facilitates cellular recovery from DNA double-strand breaks. Cancer Res. 66:9316-9322.
81. Zhang, D., H.-G. Yoon, and J. Wong. 2005. JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2). Mol. Cell. Biol. 25:6404-6414.
82. Zhang, J., M. Kalkum, B. T. Chait, and R. G. Roeder. 2002. The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol. Cell 9:611-623.
83. Zhang, X., M. Jeyakumar, S. Petukhov, and M. K. Bagchi. 1998. A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor. Mol. Endocrinol. 12:513-524.
84. 3. J. Biol. Chem. 272: 19027-19034.